ATXA Therapeutics is a clinical-stage pharmaceutical company committed to the advancement of innovative, life-changing treatments for cardiopulmonary diseases. Our research focuses on developing novel antagonists of the Thromboxane Receptor (TP), a key driver of disease within the heart & lungs. AT...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2015 (10 years)
Address:
UCD CONWAY INSTITUTE; UNIVERSITY COLLEGE DUBLIN; BELFIELD, DUBLIN 4 00000, IE
LOW
spending power
